CB Insights
Technology Market Intelligence
Technology Market Intelligence
NextCure (NASDAQ: NXTC) is a biopharmaceutical company focused on discovering and developing immuno-oncology-based drugs. The Company is applying its platforms and know-how to identify biologically relevant targets and develop improved immunotherapy ...Show all
Company (IPO / Went public)
Phone: 240-399-4900
9000 Virginia Manor
Suite 200
Beltsville, 20705
Maryland, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| NextCure | $185M | May 9, 2019 |
| See all 12 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Klrg1 binding compositions and methods of use thereof | Mar 01, 2019 | Application | |
| Antibodies for siglec-15 and methods of use thereof | Sep 21, 2017 | Application |
